SARS and MERS Viruses: Causes, Symptoms, Transmission, Diagnosis, Treatment, and Prevention

What Are SARS and MERS Viruses?

SARS (Severe Acute Respiratory Syndrome) and MERS (Middle East Respiratory Syndrome) are viral respiratory illnesses caused by coronaviruses: SARS-CoV and MERS-CoV, respectively. Both viruses belong to the coronavirus family, similar to SARS-CoV-2, and can cause severe respiratory infections that may lead to pneumonia, multi-organ complications, and death.

  • SARS emerged in 2002–2003 in China and spread globally before being contained.
  • MERS first appeared in 2012 in Saudi Arabia and continues to cause sporadic cases, mainly in the Middle East.

Virus Overview

Both SARS-CoV and MERS-CoV are enveloped RNA viruses with spike proteins that facilitate entry into human cells via specific receptors.

Virus Characteristics

  • Single-stranded RNA viruses
  • Spike glycoproteins enable host cell entry
  • Cause respiratory and systemic inflammation
  • Highly pathogenic with potential for severe disease
  • Transmission primarily via respiratory droplets
  • Can survive on surfaces for several hours

Causes of Infection

SARS and MERS infections occur through zoonotic transmission followed by human-to-human spread.

Transmission Facts

  • SARS-CoV: Initially transmitted from civet cats to humans
  • MERS-CoV: Primarily transmitted from dromedary camels to humans
  • Both can spread via respiratory droplets during close contact
  • Airborne and fomite transmission possible in healthcare settings
  • Not spread through casual contact at a distance

Risk Factors

  • Close contact with infected individuals or animals (civets, camels)
  • Healthcare workers caring for infected patients
  • Travel to regions with active outbreaks
  • Pre-existing chronic illnesses (heart disease, diabetes, lung disease)
  • Immunocompromised status

Symptoms of SARS and MERS

Symptoms vary depending on severity and patient health.

Early Symptoms

  • Fever
  • Chills
  • Muscle aches
  • Fatigue
  • Headache
  • Sore throat
  • Cough

Progressive Symptoms

  • Shortness of breath
  • Pneumonia
  • Severe cough
  • Diarrhea (more common in SARS)
  • Chest discomfort
  • Organ dysfunction in severe cases

Severe Symptoms

  • Acute respiratory distress syndrome (ARDS)
  • Kidney failure (more common in MERS)
  • Multi-organ failure
  • Shock and hypotension

Complications

  • Pneumonia leading to respiratory failure
  • Acute kidney injury (MERS higher risk)
  • Secondary bacterial infections
  • Cardiovascular complications
  • Death, particularly in elderly and immunocompromised patients

Diagnosis

Diagnosis is based on clinical evaluation, exposure history, and laboratory testing.

Diagnostic Tools

  • PCR testing for viral RNA (gold standard)
  • Serological testing for antibodies
  • Chest X-ray or CT scan to detect pneumonia
  • Blood tests for organ function
  • Screening for exposure history in outbreak areas

Treatment Options

No specific antiviral therapy has been proven fully effective for SARS or MERS; treatment is mainly supportive.

1. Supportive Care

  • Oxygen therapy
  • Mechanical ventilation in severe respiratory failure
  • Fluid management
  • Fever reducers and pain management
  • Management of complications

2. Experimental Therapies

  • Antivirals (e.g., ribavirin, lopinavir/ritonavir) in some cases
  • Interferon therapy
  • Convalescent plasma therapy (investigational)

3. Severe Case Management

  • Intensive care for multi-organ failure
  • Renal replacement therapy if kidney failure occurs
  • Continuous monitoring for secondary infections

Transmission Control Practices

  • Isolation of infected patients
  • Use of personal protective equipment (PPE) for healthcare workers
  • Hand hygiene and respiratory etiquette
  • Environmental disinfection
  • Avoiding contact with known animal reservoirs (civets, camels)

Prevention Strategies

1. Personal Protection

  • Masks in high-risk settings
  • Hand washing and sanitization
  • Avoid touching face with unwashed hands
  • Avoid close contact with sick individuals

2. Community Measures

  • Rapid identification and isolation of cases
  • Quarantine of exposed individuals
  • Travel advisories during outbreaks
  • Public awareness campaigns

3. Animal and Environmental Measures

  • Avoid consumption of raw or undercooked animal products
  • Prevent contact with potential animal reservoirs
  • Regulate animal markets in endemic regions

Prognosis

  • SARS: Approximate fatality rate of 9–10%, higher in elderly
  • MERS: Fatality rate around 35%, particularly in patients with comorbidities
  • Early detection and supportive care improve survival
  • Long-term complications may include lung damage and reduced respiratory capacity

Frequently Asked Questions (FAQ)

Are SARS and MERS contagious?

Yes, both can spread between humans through close contact and respiratory droplets.

Can SARS or MERS return after recovery?

Reinfection is rare; immunity may provide temporary protection.

Is there a vaccine?

No widely available vaccine exists yet, though research continues.

Are children affected?

Children can be infected, but symptoms are often milder.

Can animals transmit these viruses to humans?

Yes, civets (SARS) and camels (MERS) are known reservoirs.

Conclusion

SARS and MERS are severe respiratory illnesses caused by coronaviruses with high pathogenic potential. Early recognition, supportive treatment, and strict infection control measures are crucial to prevent outbreaks and reduce mortality. Understanding transmission pathways, symptoms, and risk factors allows for better prevention and management strategies in both healthcare and community settings.

Want to learn more? Check these out